Introduction: Pathogenic variants in the PIEZO family member 2 (PIEZO2) gene are known to cause Gordon syndrome (GS), Marden-Walker syndrome (MWS), and distal arthrogryposis type 5 (DA5). Out of these, MWS has a recognizable phenotype that can be discerned easily, but the distinction between GS and DA5 is less evident. Few children with pathogenic PIEZO2 variants have been reported to show posterior fossa anomalies. Methods and Results: By candidate gene targeting guided by proper clinical evaluation and neuroimaging findings, a patient with classic MWS harboring a de novo novel variant (c.8237G>A, p.W2746*) in the C-terminal region of PIEZO2 was identified. In addition, another girl with the typical clinical features of GS is also described carrying the most prevalent reported variant (c.8057G>A, p.R2686H) in PIEZO2. The brain MRI of the 2 patients showed Dandy-Walker malformation (DWM). Diffusion tensor imaging visualized anteroposterior and downward aligned thin middle cerebellar peduncle. The association of DWM with arthrogryposis in the presence of PIEZO2 variants remains quite interesting and provides more evidence that PIEZO2 plays a role in the development of hindbrain although the underlying mechanism remains unclear. Moreover, the 2 girls had distinct foot patterning in the form of shortening of the first and fifth toes. Conclusion: Phenotype analysis and a comprehensive review of the literature strongly support the previously published data and corroborate the evidence that heterozygous PIEZO2- related disorders represent a continuum with overlapping phenotypic features.

1.
Alisch
F
,
Weichert
A
,
Kalache
K
,
Paradiso
V
,
Longardt
AC
,
Dame
C
,
Familial Gordon syndrome associated with a PIEZO2 mutation
.
Am J Med Genet A
.
2017
;
173
(
1
):
254
9
.
2.
Chokshi
FH
,
Poretti
A
,
Meoded
A
,
Huisman
TA
.
Normal and abnormal development of the cerebellum and brainstem as depicted by diffusion tensor imaging
.
Semin Ultrasound CT MR
.
2011
;
32
(
6
):
539
54
.
3.
Coste
B
,
Houge
G
,
Murray
MF
,
Stitziel
N
,
Bandell
M
,
Giovanni
MA
,
Gain-of-function variants in the mechanically activated ion channel PIEZO2 cause a subtype of distal arthrogryposis
.
Proc Natl Acad Sci U S A
.
2013
;
110
(
12
):
4667
72
.
4.
Gordon
H
,
Davies
D
,
Berman
M
.
Camptodactyly, cleft palate, and club foot. A syndrome showing the autosomal-dominant pattern of inheritance
.
J Med Genet
.
1969
;
6
(
3
):
266
74
.
5.
Ma
Y
,
Zhao
Y
,
Cai
Z
,
Hao
X
.
Variants in PIEZO2 contribute to Gordon syndrome, Marden-Walker syndrome and distal arthrogryposis: A bioinformatics analysis of mechanisms
.
Exp Ther Med
.
2019
;
17
(
5
):
3518
24
.
6.
Mahmud
AA
,
Nahid
NA
,
Nassif
C
,
Sayeed
MS
,
Ahmed
MU
,
Parveen
M
,
Loss of the proprioception and touch sensation channel PIEZO2 in siblings with a progressive form of contractures
.
Clin Genet
.
2017
;
91
(
3
):
470
5
.
7.
McMillin
MJ
,
Beck
AE
,
Chong
JX
,
Shively
KM
,
Buckingham
KJ
,
Gildersleeve
HI
,
Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5
.
Am J Hum Genet
.
2014
;
94
(
5
):
734
44
.
8.
Okubo
M
,
Fujita
A
,
Saito
Y
,
Komaki
H
,
Ishiyama
A
,
Takeshita
E
,
A family of distal arthrogryposis type 5 due to a novel PIEZO2 mutation
.
Am J Med Genet A
.
2015
;
167A
(
5
):
1100
6
.
9.
Seidahmed
MZ
,
Maddirevula
S
,
Miqdad
AM
,
Al Faifi
A
,
Al Samadi
A
,
Alkuraya
FS
.
Confirming the involvement of PIEZO2 in the etiology of Marden-Walker syndrome
.
Am J Med Genet A
.
2021
;
185
(
3
):
945
8
.
10.
Woo
SH
,
Ranade
S
,
Weyer
AD
,
Dubin
AE
,
Baba
Y
,
Qiu
Z
,
Piezo2 is required for Merkel-cell mechanotransduction
.
Nature
.
2014
;
509
(
7502
):
622
6
.
11.
Zapata-Aldana
E
,
Al-Mobarak
SB
,
Karp
N
,
Campbell
C
.
Distal arthrogryposis type 5 and PIEZO2 novel variant in a Canadian family
.
Am J Med Genet A
.
2019
;
179
(
6
):
1034
41
.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.